HTG Molecular Diagnostics, Inc.
🏢 View company profile →8Patents
8Active
8Granted
42Portfolio score
Filing activity: Dec 7, 2011 → Apr 8, 2019
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8741564B2 | Quantitative nuclease protection assay (QNPA) and sequencing (QNPS) improvements | Chemistry; Metallurgy | 121 | Active |
| US10294515B2 | Methods of detecting gene fusions | Chemistry; Metallurgy | 1 | Active |
| US9758829B2 | Molecular malignancy in melanocytic lesions | Chemistry; Metallurgy | 1 | Active |
| US9512469B2 | Methods of co-detecting MRNA and small non-coding RNA | Chemistry; Metallurgy | 1 | Active |
| US9765385B2 | Nuclease protection methods for detection of nucleotide variants | Chemistry; Metallurgy | 1 | Active |
| US11384399B2 | Methods for subtyping diffuse large B-cell lymphoma (DLBCL) | Chemistry; Metallurgy | 0 | Active |
| US11268133B2 | Methods of detecting gene fusions | Chemistry; Metallurgy | 0 | Active |
| US12104206B2 | Method of direct target sequencing using nuclease protection | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.